NICE guidance in schizophrenia: How generalisable are drug trials?

Aims and method: To test the National Institute for Clinical Excellence (NICE) assertion that characteristics of participants in the majority of clinical drug trials in schizophrenia do not reflect clinical practice. In particular they were concerned about the relative exclusion of women, older adul...

Descrizione completa

Dettagli Bibliografici
Autore principale: Burns, T
Natura: Journal article
Lingua:English
Pubblicazione: 2006

Documenti analoghi